We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ilika Plc | LSE:IKA | London | Ordinary Share | GB00B608Z994 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.18% | 21.50 | 21.00 | 22.00 | 22.50 | 21.50 | 21.50 | 863,216 | 08:00:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 2.09M | -4.81M | -0.0288 | -7.47 | 35.55M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/4/2023 08:34 | You lack perspective I’m afraid. It’s not your fault. Your brain won’t allow it. But you should try and see both sides of the conversation if you can. Risk/reward good/bad loss/gain. All part of the assessment in shares and of course in life. Good luck. I think you may need it :( | kenjen1 | |
11/4/2023 07:35 | So, we are underway. Can only assume from the Rns that both product and process qualification is complete? If that’s the case then great news and well done ilika :) from here I am hoping we will see the continuation of production and commercialisation. First of many customers and heres hoping this is picked up by a few press outlets! | kenjen1 | |
11/4/2023 06:50 | A landmark announcement. Stereax is under appreciated by many but has enormous long term potential if medical advances accelerate. Yes it has taken forever and been bumpy but it is now real. Goliath following the same path offers further LT upside. | robertspc1 | |
05/4/2023 07:04 | Ken Jen I agree but I think it will decline further yet | kenbos | |
05/4/2023 06:48 | We all know the delays in bringing a product to market here have decimated the share price, however the Jan 19th update states that commercial sales of stereax will be in q2 23. So maximum of 2 months till they announce this and a signed deal with cirtec? I’m thinking this is a good time to get in! | kenjen1 | |
03/4/2023 13:38 | As I said I’m on the fence, I see risk here but I also see reward. Perspective is key here. Fingers crossed | kenjen1 | |
03/4/2023 11:47 | Yeah I do understand and have confirmation from the business that the oem is responsible for that not ilika. I am balanced here. Are you? | kenjen1 | |
03/4/2023 09:29 | Time will tell, I’m on the fence. For one management have consistently missed their own deadlines. On the other hand the demand for medical implants and neuro modulation is through the roof, if only they had a reliable energy source = stereax. It will be interesting either way | kenjen1 | |
03/4/2023 07:33 | Two 250k trades this morning already… Buys or sells? Who knows these days… Either way I think we are about to find out soon if stereax is a viable product. We are almost a year delayed in the release of these devices but and if it’s a big if we do see them released to market then happy days. Any other delays and we are done. As would management I suspect. Guess we will find out soon. | kenjen1 | |
28/3/2023 12:01 | Some bigger trades today. Not sure if buy or sell though. We must surely be close to having stereax product finished ready for commercial sales!! You never know with ilika. They could finally deliver a viable product but given the history could easily fail again to meet their own deadlines. Hold and see is the only option I think. 🤞 | kenjen1 | |
28/3/2023 07:07 | Do we have a product yet? Anyone seen a product??? ;) | kenjen1 | |
20/3/2023 22:19 | Next stop 21p | phil2003 | |
09/3/2023 08:11 | Gelion acquiring JM battery IP. Potentially selling on Silicon anode IP to a third party for 1.25m pounds. Maybe IKA ... think they use silicon anode tech | robertspc1 | |
08/3/2023 20:10 | I think even the p.i’s are bailing out now.. Soon it’ll just be JimmyAnn (ignoring the last 10 years of jam tomorrow whilst the big boys overtook ilika) shouting about their huge ‘potentialR | phil2003 | |
03/3/2023 14:28 | JimmyAnn, your eloquent, fact filled rebuttal to HB has won me over.. you’re right, this isn’t just another grant funded pipe dream with nothing tangible to show for 10 years of NPD. Your naive comments about day traders here is very telling, fyi, attempting to short term trade anything with ilika’s spread is the work of the 76% club. You're welcome. | phil2003 | |
03/3/2023 00:00 | Ah. You're one of those. 'nough said. | horneblower | |
02/3/2023 23:56 | You have no idea how long I have held these shares so stop your moronic assumptions! What we all know about you ROGK/Homeblower is that you have no regard for this company and you are only here for constant criticism at every aspect of this company. The share price was over £2 at one stage. Why didn't you exit? That is if you really hold these shares. You are a complete Moron!! | jimmyann | |
02/3/2023 16:52 | Dear Ann and jimmy, You have been loyally pushing this company for several years (is it three or four?) and complaining bitterly about posters saying negative things about the company, the board, the science, the lack of patents etc etc. You keep saying that we talk a lot of twoddle and ask why don't we all shove off, and that the gyrations in the shareprice is purely to do with day-traders. The fact is that this company has been stringing shareholders along for over 10 years (yes ten years) in which time it has not managed to get a single product to market and therefore has achieved zero product sales. Surely there must come a time when you should ask yourselves, "Is the company ever going to make it, or is it just one of those "lifestyle" companies who's board cares nothing for the shareholders and are purely interested in hanging on to their well-paid jobs for as long as possible? Ask yourselves the question and stop slanging other posters who may know more than you. | horneblower |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions